Importantly, our in vivo experiments with AS1517499 have confirmed its expected antifibrotic effects, including inhibition of keloid proliferation, induction of cell apoptosis, and decrease in α-SMA+ fibroblasts, highlighting the clinical and translational prospect of our findings. The gene discussed is ACTA1; the disease is keloid.